190 related articles for article (PubMed ID: 25593792)
1. Long-term therapeutic efficacy of allogenic bone marrow transplantation in a patient with mucopolysaccharidosis IVA.
Chinen Y; Higa T; Tomatsu S; Suzuki Y; Orii T; Hyakuna N
Mol Genet Metab Rep; 2014; 1():31-41. PubMed ID: 25593792
[TBL] [Abstract][Full Text] [Related]
2. Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome.
Tomatsu S; Sawamoto K; Alméciga-Díaz CJ; Shimada T; Bober MB; Chinen Y; Yabe H; Montaño AM; Giugliani R; Kubaski F; Yasuda E; Rodríguez-López A; Espejo-Mojica AJ; Sánchez OF; Mason RW; Barrera LA; Mackenzie WG; Orii T
Drug Des Devel Ther; 2015; 9():1937-53. PubMed ID: 25897204
[TBL] [Abstract][Full Text] [Related]
3. Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management.
Sawamoto K; Álvarez González JV; Piechnik M; Otero FJ; Couce ML; Suzuki Y; Tomatsu S
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102177
[TBL] [Abstract][Full Text] [Related]
4. Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model.
Sawamoto K; Tomatsu S
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450640
[TBL] [Abstract][Full Text] [Related]
5. Therapies of mucopolysaccharidosis IVA (Morquio A syndrome).
Tomatsu S; Alméciga-Díaz CJ; Barbosa H; Montaño AM; Barrera LA; Shimada T; Yasuda E; Mackenzie WG; Mason RW; Suzuki Y; Orii KE; Orii T
Expert Opin Orphan Drugs; 2013 Oct; 1(10):805-818. PubMed ID: 25419501
[TBL] [Abstract][Full Text] [Related]
6. Bone Growth Induction in Mucopolysaccharidosis IVA Mouse.
Rintz E; Herreño-Pachón AM; Celik B; Nidhi F; Khan S; Benincore-Flórez E; Tomatsu S
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373036
[TBL] [Abstract][Full Text] [Related]
7. Mucopolysaccharidosis IVA and glycosaminoglycans.
Khan S; Alméciga-Díaz CJ; Sawamoto K; Mackenzie WG; Theroux MC; Pizarro C; Mason RW; Orii T; Tomatsu S
Mol Genet Metab; 2017; 120(1-2):78-95. PubMed ID: 27979613
[TBL] [Abstract][Full Text] [Related]
8. [Mucopolysaccharidosis IVA (Morquio A syndrome): clinical, biological and therapeutic aspects].
Bouzidi H; Khedhiri S; Laradi S; Ferchichi S; Daudon M; Miled A
Ann Biol Clin (Paris); 2007; 65(1):5-11. PubMed ID: 17264033
[TBL] [Abstract][Full Text] [Related]
9. The characterisation of pulmonary function in patients with mucopolysaccharidoses IVA: A longitudinal analysis.
Kenth JJ; Thompson G; Fullwood C; Wilkinson S; Jones S; Bruce IA
Mol Genet Metab Rep; 2019 Sep; 20():100487. PubMed ID: 31341787
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell transplantation for Morquio A syndrome.
Yabe H; Tanaka A; Chinen Y; Kato S; Sawamoto K; Yasuda E; Shintaku H; Suzuki Y; Orii T; Tomatsu S
Mol Genet Metab; 2016 Feb; 117(2):84-94. PubMed ID: 26452513
[TBL] [Abstract][Full Text] [Related]
11. Development of MPS IVA mouse (Galnstm(hC79S.mC76S)slu) tolerant to human N-acetylgalactosamine-6-sulfate sulfatase.
Tomatsu S; Gutierrez M; Nishioka T; Yamada M; Yamada M; Tosaka Y; Grubb JH; Montaño AM; Vieira MB; Trandafirescu GG; Peña OM; Yamaguchi S; Orii KO; Orii T; Noguchi A; Laybauer L
Hum Mol Genet; 2005 Nov; 14(22):3321-35. PubMed ID: 16219627
[TBL] [Abstract][Full Text] [Related]
12. Liver-Targeted AAV8 Gene Therapy Ameliorates Skeletal and Cardiovascular Pathology in a Mucopolysaccharidosis IVA Murine Model.
Sawamoto K; Karumuthil-Melethil S; Khan S; Stapleton M; Bruder JT; Danos O; Tomatsu S
Mol Ther Methods Clin Dev; 2020 Sep; 18():50-61. PubMed ID: 32577432
[TBL] [Abstract][Full Text] [Related]
13. Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment.
Tomatsu S; Montaño AM; Oikawa H; Smith M; Barrera L; Chinen Y; Thacker MM; Mackenzie WG; Suzuki Y; Orii T
Curr Pharm Biotechnol; 2011 Jun; 12(6):931-45. PubMed ID: 21506915
[TBL] [Abstract][Full Text] [Related]
14. Chondroitin sulfate disaccharide is a specific and sensitive biomarker for mucopolysaccharidosis type IVA.
Chin SJ; Saville JT; McDermott BK; Zankl A; Fletcher JM; Fuller M
JIMD Rep; 2020 Sep; 55(1):68-74. PubMed ID: 32905071
[TBL] [Abstract][Full Text] [Related]
15. Bio-Plex immunoassay measuring the quantity of lysosomal
Chuang CK; Lin HY; Wang TJ; Huang SF; Lin SP
BMJ Open; 2017 Jul; 7(7):e014410. PubMed ID: 28710204
[TBL] [Abstract][Full Text] [Related]
16. Characterization of New Proteomic Biomarker Candidates in Mucopolysaccharidosis Type IVA.
Álvarez VJ; Bravo SB; Chantada-Vazquez MP; Colón C; De Castro MJ; Morales M; Vitoria I; Tomatsu S; Otero-Espinar FJ; Couce ML
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379360
[TBL] [Abstract][Full Text] [Related]
17. A 9-Month-Old with Skeletal Abnormalities and a Consanguineous Sibling with Mucopolysaccharidosis IVA: The Role of Urinary Glycosaminoglycan Testing in Disease Diagnosis and Treatment Monitoring.
Goldman E; Vu A; Dietz K; Thomas SN
Clin Med Insights Case Rep; 2021; 14():1179547621999409. PubMed ID: 33746520
[TBL] [Abstract][Full Text] [Related]
18. Heteroallelic missense mutations of the galactosamine-6-sulfate sulfatase (GALNS) gene in a mild form of Morquio disease (MPS IVA).
Cole DE; Fukuda S; Gordon BA; Rip JW; LeCouteur AN; Rupar CA; Tomatsu S; Ogawa T; Sukegawa K; Orii T
Am J Med Genet; 1996 Jun; 63(4):558-65. PubMed ID: 8826435
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Human Recombinant N-Acetylgalactosamine-6-Sulfate Sulfatase Produced in Pichia pastoris as Potential Enzyme for Mucopolysaccharidosis IVA Treatment.
Rodríguez-López A; Pimentel-Vera LN; Espejo-Mojica AJ; Van Hecke A; Tiels P; Tomatsu S; Callewaert N; Alméciga-Díaz CJ
J Pharm Sci; 2019 Aug; 108(8):2534-2541. PubMed ID: 30959056
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of Morquio A syndrome: an autopsied case reveals systemic storage disorder.
Yasuda E; Fushimi K; Suzuki Y; Shimizu K; Takami T; Zustin J; Patel P; Ruhnke K; Shimada T; Boyce B; Kokas T; Barone C; Theroux M; Mackenzie W; Nagel B; Ryerse JS; Orii KE; Iida H; Orii T; Tomatsu S
Mol Genet Metab; 2013 Jul; 109(3):301-11. PubMed ID: 23683769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
